United States Halitosis Treatment Market Research Report to 2032
ID: MRFR/Pharma/11776-US | 100 Pages | Author: MRFR Research Team| December 2023
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
On the South American front, there is also a positive trajectory for the treatment of bad breath. The market is not limited to North America, as South America is also witnessing encouraging growth in addressing halitosis.
The lion's share of the American market for bad breath treatment is in the United States, divided into North America and South America. Among them, North America is the leader in this market, and its expansion is linked to the rise in the number of people dealing with bad breath and gum problems. Many folks are investing their money in purchasing oral rinses or mouthwashes. In 2013, a whopping USD 810 million was spent on treating bad breath in the U.S. The Centers for Disease Control and Prevention have highlighted a rising trend in periodontal disease among the U.S. population, with 47.2% of people affected. The aging population is also contributing significantly to the growth of this market in the U.S., with 4.7 million people over 30 facing oral health issues, as reported by the Centers for Disease Control and Prevention. These figures serve as clear indicators of the market's growth.
On the South American front, there is also a positive trajectory for the treatment of bad breath. The market is not limited to North America, as South America is also witnessing encouraging growth in addressing halitosis.
The most significant portion of the American market for treating bad breath is found in the United States, with North America and South America being the two major regions. North America, particularly the U.S., stands out as the primary contributor to this market. The growth here is linked to the increasing number of people facing issues related to bad breath and gum diseases. A considerable amount of money is being spent by individuals on oral rinses and mouthwashes. In 2013, an impressive USD 810 million was dedicated to treating bad breath in the U.S. The Centers for Disease Control and Prevention have drawn attention to the escalating prevalence of periodontal disease in the U.S. population, affecting 47.2% of people. Additionally, the aging population is playing a pivotal role in the market's growth in the U.S., with 4.7 million individuals over 30 experiencing oral health problems, as per the Centers for Disease Control and Prevention. These statistics undeniably point towards the upward trajectory of the market.
Turning our focus to South America, there is a positive trend in the realm of bad breath treatment. The market is not confined solely to North America, as South America is also experiencing favorable growth in addressing halitosis.
In summary, the American market for bad breath treatment is dominated by North America, especially the United States. The surge in the number of people grappling with bad breath and gum problems is fueling this growth. A significant portion of consumer spending is directed towards oral rinses and mouthwashes. The U.S. spent a considerable USD 810 million on bad breath treatment in 2013. The Centers for Disease Control and Prevention highlight the increasing prevalence of periodontal disease, affecting nearly half of the U.S. population. The aging demographic further contributes to the market's expansion, with millions facing oral health issues. South America is not left behind, showing positive growth in the treatment of bad breath.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)